Tag Archives: Viekira Pak

December, 2016

12 December
Express Scripts Announces Enhancements to Industry Leading SafeGuardRx Programs

LOUIS, Dec. 12, 2016 /PRNewswire/ — As part of its ongoing mission to put medicine within reach, Express Scripts (NASDAQ: ESRX) today announced enhancements to its landmark SafeGuardRxSM programs focusing on hepatitis C and cancer. Beginning Jan. 1, 2017, the company’s Hepatitis Cure Value Program® will now include both Viekira …
Share

25 April
FDA Expands Approval of AbbVie’s Viekira Pak for Use without RBV

NORTH CHICAGO, Ill., April 25, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the use of VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without ribavirin (RBV) in …
Share

26 February
AbbVie Announces Positive CHMP Opinion for Viekirax without Ribavirin in HCV

NORTH CHICAGO, Ill., Feb. 26, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for the use of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) without …
Share

8 January
FDA Grants Priority Review to Expanded Indication for AbbVie’s Viekira Pak

NORTH CHICAGO, Ill., Jan. 7, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) and granted priority review for VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without ribavirin (RBV) in …
Share

2 December
Hepatitis C Deaths Still On Rise

The headlines are compelling when it comes to new medications for treating infection with the hepatitis C virus (HCV): Harvoni cures up to 98% of patients with genotype 1 HCV. Viekira Pak cures 100% of those with genotype 1b HCV. Sovaldi cures 95% of those with genotype 2 HCV. With …
Share